+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Prenatal and Newborn Genetic Testing Market to 2027 - Global Analysis and Forecasts By Product, Disease, End User and Geography

  • ID: 4825235
  • Report
  • Region: Global
  • 194 pages
  • The Insight Partners
1 of 3
The global Prenatal and Newborn Genetic Testing Market is expected to reach US$ 11,204.74 Mn in 2027 from US$ 4,034.37 in 2018. The market is estimated to grow with a CAGR of 12.2% from 2019-2027.

The key factors that are driving the growth of the significant increase in the prevalence of genetic diseases among infants, supportive government for promoting the use of prenatal and newborn testing and increasing birth rate are boosting the market over the years. In addition, the growth opportunities in emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years.

Several types of genetic diseases affect the fetuses in the womb. The way in which these genetic diseases are inherited helps to determine the risk that they pose on pregnancy as well as the risk of its recurrence. The risk of having genetic diseases in babies is high in cases where the parents have another child with a genetic disease, family history of a genetic disorder, or if either of a parent has a chromosomal abnormality. There is a significant prevalence of genetic diseases among infants. Moreover, these diseases are also responsible for infant mortality across the globe. For instance, according to the World Health Organization 2016, an estimated 7.9 million infants across the world are born with genetic defects. Moreover, according to the Centers for Disease Control and Prevention (CDC), birth defects affects every 1 in 33 babies born in the US. On the other hand, chromosomal abnormalities such as Down syndrome affects 1 in 691 babies born in the US, as per the CDC’s data in 2017. Thus, the high prevalence of genetic diseases among infants account for the increasing demands for prenatal and newborn genetic tests, thereby contributing to the growth of the market.

Global Prenatal and Newborn Genetic Testing Market was segmented by product, disease indication, and end user. The product segment was further divided as diagnostic and screening. On the basis of disease indication, the market is segmented into the cystic fibrosis, sickle cell anemia, Down syndrome, phenylketonuria, and other diseases. Based on the end user, the prenatal and newborn genetic testing market is segmented into hospitals and clinics, diagnostic centers, other end users. The hospitals and clinics held a major market share among the end user segment as they are the primary healthcare centres for all patients.

Some of the major primary and secondary sources included in the report for the Prenatal and Newborn Genetic Testing Market are World Health Organization, UAE Genetic Diseases Association, Centre for Arab Genomic Studies, National Health Service (NHS), Centers for Disease Control and Prevention, National Human Genome Research Institute (US), Florida Department of Health and others.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Prenatal and Newborn Genetic Testing Market - By Product
1.3.2 Global Prenatal and Newborn Genetic Testing Market - By Disease Indication
1.3.3 Global Prenatal and Newborn Genetic Testing Market - By End User
1.3.4 Global Prenatal and Newborn Genetic Testing Market - By Geography

2. Global Prenatal And Newborn Genetic Testing Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Prenatal And Newborn Genetic Testing- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South & Central America - PEST Analysis

5. Global Prenatal And Newborn Genetic Testing Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 High Prevalence of Genetic Diseases in Infants
5.1.2 Government Support to Promote Prenatal and Newborn Testing
5.1.3 Increasing Birth Rate
5.2 Key Market Restraints
5.2.1 Risks Associated with Prenatal Testing
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Digital Microfluidics Poses a New Opportunity Area for the Newborn Screening Market
5.5 Impact Analysis

6. Prenatal And Newborn Genetic Testing Market - Global Analysis
6.1 Global Prenatal And Newborn Genetic Testing Market Revenue Forecasts And Analysis
6.2 Global Prenatal And Newborn Genetic Testing Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players
6.3.1 F. Hoffmann La-Roche Ltd.
6.3.2 Laboratory Corporation of America Holdings (Sequenom)
6.3.3 PerkinElmer, Inc.

7. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Product
7.1 Overview
7.2 Global Prenatal and Newborn Genetic Testing Market Share By Product 2018 & 2027 (%)
7.3 Diagnostic Market
7.3.1 Overview
7.3.2 Diagnostic Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Spectrophotometer Market
7.3.3.1 Overview
7.3.3.2 Spectrophotometer Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4 Polymerase Chain Reaction Market
7.3.4.1 Overview
7.3.4.2 Polymerase Chain Reaction Market Revenue and Forecast to 2027 (US$ Mn)
7.3.5 Fluorescence in-situ Hybridization Market
7.3.5.1 Overview
7.3.5.2 Fluorescence in-situ Hybridization Market Revenue and Forecast to 2027 (US$ Mn)
7.3.6 Array Comparative Genomic Hybridization Market
7.3.6.1 Overview
7.3.6.2 Array Comparative Genomic Hybridization Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Screening Market
7.4.1 Overview
7.4.2 Screening Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Maternal Serum Screening Market
7.4.3.1 Overview
7.4.3.2 Maternal Serum Screening Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Chorionic Villus Sampling Market
7.4.4.1 Overview
7.4.4.2 Chorionic Villus Sampling Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Amniocentesis Market
7.4.5.1 Overview
7.4.5.2 Amniocentesis Market Revenue and Forecast to 2027 (US$ Mn)
7.4.6 Non-Invasive Prenatal Testing Market
7.4.6.1 Overview
7.4.6.2 Non-Invasive Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)

8. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Disease Indication
8.1 Overview
8.2 Global Prenatal and Newborn Genetic Testing Market Share By Disease Indication 2018 & 2027 (%)
8.3 Cystic Fibrosis
8.3.1 Overview
8.3.2 Cystic Fibrosis Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Sickle Cell Anemia
8.4.1 Overview
8.4.2 Sickle Cell Anemia Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Down Syndrome
8.5.1 Overview
8.5.2 Downs Syndrome Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Phenylketonuria
8.6.1 Overview
8.6.2 Phenylketonuria Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Other Diseases
8.7.1 Overview
8.7.2 Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

9. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - End User
9.1 Overview
9.2 Global Prenatal And Newborn Genetic Testing Market Share By End User 2018 & 2027 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Diagnostics Centers
9.4.1 Overview
9.4.2 Diagnostics Centers Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Other End Users
9.5.1 Overview
9.5.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)

10. Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 - Geographical Analysis
10.1 North America Prenatal And Newborn Genetic Testing Market
10.1.1 Overview
10.1.2 North America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.3.1 North America Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.2 North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.5 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Country (%)
10.3 US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
10.3.1 US Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.1.1 US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.1.1.1 US Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.1.1.2 US Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.1.2 US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.3.1.3 US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4 Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
10.4.1 Canada Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.1.1 Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.1.1.1 Canada Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.1.1.2 Canada Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.1.2 Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.4.1.3 Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5 Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
10.5.1 Mexico Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.1.1 Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.1.1.1 Mexico Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.1.1.2 Mexico Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.1.2 Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.5.1.3 Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6 Europe Prenatal And Newborn Genetic Testing Market
10.6.1 Overview
10.6.2 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027 (US$ Mn)
10.6.3 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.3.1 Europe Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.3.2 Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.4 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.5 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.6 Europe Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
10.6.7 Germany Prenatal and Newborn Genetic Testing Market
10.6.7.1 Germany Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.7.2 Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.7.2.1 Germany Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.7.2.2 Germany Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.7.3 Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.7.4 Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.8 UK Prenatal and Newborn Genetic Testing Market
10.6.8.1 UK Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.8.2 UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.8.2.1 UK Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.8.2.2 UK Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.8.3 UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.8.4 UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.9 France Prenatal and Newborn Genetic Testing Market
10.6.9.1 France Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.9.2 France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.9.2.1 France Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.9.2.2 France Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.9.3 France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.9.4 France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.10 Spain Prenatal and Newborn Genetic Testing Market
10.6.10.1 Spain Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.10.2 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.10.2.1 Spain Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.10.2.2 Spain Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.10.3 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.10.4 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.11 Italy Prenatal and Newborn Genetic Testing Market
10.6.11.1 Italy Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.11.2 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.11.2.1 Italy Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.11.2.2 Italy Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.11.3 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.11.4 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7 Asia Pacific Prenatal And Newborn Genetic Testing Market
10.7.1 Overview
10.7.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.3 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.3.1 Asia Pacific Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.7.3.2 Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.7.4 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.7.5 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
10.8.1 China Prenatal And Newborn Genetic Testing Market
10.8.1.1 China Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.1.2 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.1.2.1 China Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.1.2.2 China Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.1.3 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.1.4 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8.2 Japan Prenatal And New born Genetic Testing Market
10.8.2.1 Japan Prenatal And New Born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2.2 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.2.2.1 Japan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.2.2.2 Japan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.2.3 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.2.4 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8.3 India Prenatal And New born Genetic Testing Market
10.8.3.1 India Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.3.2 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.3.2.1 India Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.3.2.2 India Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.3.3 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.3.4 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8.4 Australia Prenatal And New Born Genetic Testing Market
10.8.4.1 Australia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.4.2 Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.4.2.1 Australia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.4.2.2 Australia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.4.3 Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.4.4 Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8.5 South Korea Prenatal And Newborn Genetic Testing Market
10.8.5.1 South Korea Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.5.2 South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.5.2.1 South Korea Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.5.2.2 South Korea Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.5.3 South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.5.4 South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.9 Middle East And Africa Prenatal And Newborn Genetic Testing Market
10.9.1 Overview
10.9.2 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.9.2.1 Middle East & Africa Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.9.2.2 Middle East & Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.9.3 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.9.4 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.10 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
10.10.1 UAE Prenatal And New born Genetic Testing Market
10.10.1.1 UAE Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.10.1.2 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.10.1.2.1 UAE Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.1.2.2 UAE Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.1.3 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.10.1.4 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.10.2 Saudi Arabia Prenatal And Newborn Genetic Testing Market
10.10.2.1 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.10.2.2 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.10.2.2.1 Saudi Arabia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.2.2.2 Saudi Arabia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.2.3 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.10.2.4 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.10.3 South Africa Prenatal And Newborn Genetic Testing Market
10.10.3.1 South Africa Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.10.3.2 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.10.3.2.1 South Africa Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.3.2.2 South Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.3.3 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.10.3.4 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.11 South And Central America Prenatal And Newborn Genetic Testing Market
10.11.1 Overview
10.11.2 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027 (US$ Mn)
10.11.3 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.11.3.1 South and Central America Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.3.2 South and Central America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.4 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.11.5 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.11.6 South and Central America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
10.11.7 Brazil Prenatal and Newborn Genetic Testing Market
10.11.7.1 Brazil Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.11.7.2 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.11.7.2.1 Brazil Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.7.2.2 Brazil Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.7.3 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.11.7.4 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.11.8 Argentina Prenatal and Newborn Genetic Testing Market
10.11.8.1 Argentina Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.11.8.2 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.11.8.2.1 Argentina Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.8.2.2 Argentina Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.8.3 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.11.8.4 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Prenatal And Newborn Genetic Testing Market - Industry Landscape
11.1 Overview
11.2 Comparative Company Analysis
11.3 Growth Strategies Done by the Companies in the Market, (%)
11.4 Organic Developments
11.4.1 Overview
11.5 Inorganic Developments
11.5.1 Overview

12. Prenatal And Newborn Genetic Testing Market-Key Company Profiles
12.1 Abbott
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Quest Diagnostics Incorporated
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Ravgen
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Qiagen N.V.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Information
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Berry Gene
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PerkinElmer, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Natera, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Laboratory Corporation Of America Holdings (Sequenom)
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Illumina, Inc.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Financial Overview
12.11.4 Product Portfolio
12.11.5 SWOT Analysis
12.11.6 Key Developments

13. Appendix
13.1 About The Publisher
13.2 Glossary Of Terms
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott
  • Quest Diagnostics Incorporated
  • Ravgen
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • F. Hoffmann La-Roche Ltd.
  • Qiagen
  • Berry Gene
  • PerkinElmer, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings (Sequenom)
Note: Product cover images may vary from those shown
Adroll
adroll